ITGAM and neoplasm: Previous studies found that at 3 weeks post-implantation of 4T1 cells, CD11b+Gr1+ cells comprised approximately 70% of the viable immune cells in the lungs, accompanied by a gradual increase in lung-infiltrating tumor cells [24].